Evaluation of proposed limits for intermittent noise exposures with temporary threshold shift as a criterion.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4659532)

Published in Am Ind Hyg Assoc J on August 01, 1972

Authors

M Schmidek, T Henderson, B Margolis

Articles by these authors

(truncated to the top 100)

Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11

The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell (1992) 8.20

Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature (1993) 6.38

Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84

Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell (1991) 5.65

Roles of nonphysician clinicians as autonomous providers of patient care. JAMA (1998) 4.63

PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell (1991) 3.95

A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos. Cell (1993) 3.94

Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J Cell Biol (2001) 3.84

Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol (1992) 3.42

The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science (1993) 3.12

Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06

ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol (2000) 2.90

SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J (1992) 2.82

Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques (2000) 2.81

Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem (1998) 2.71

The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol (1996) 2.57

A phosphotyrosine interaction domain. Cell (1995) 2.28

Efficacy of corticosteroids in suppression of intimal hyperplasia. J Vasc Surg (1989) 2.19

A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem (1994) 2.06

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88

The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J (1994) 1.87

Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J Biol Chem (1998) 1.83

Apical junctional complexes and cell polarity. Kidney Int (2007) 1.64

Molecular cloning and characterization of Pals, proteins associated with mLin-7. J Biol Chem (2000) 1.64

The transcription factor snail represses Crumbs3 expression and disrupts apico-basal polarity complexes. Oncogene (2008) 1.56

Blood volume redistribution during cross-clamping of the descending aorta. Anesth Analg (1994) 1.52

Desmoplastic trichilemmoma of the upper eyelid. Eye (Lond) (1999) 1.48

Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J (1997) 1.48

The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J Biol Chem (1998) 1.45

Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg (2000) 1.43

Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure (1994) 1.43

Bronchoscopy for hemoptysis. Chest (1990) 1.38

The cloning of Grb10 reveals a new family of SH2 domain proteins. Oncogene (1995) 1.35

Fc epsilon R1-mediated tyrosine phosphorylation of multiple proteins, including phospholipase C gamma 1 and the receptor beta gamma 2 complex, in RBL-2H3 rat basophilic leukemia cells. Mol Cell Biol (1992) 1.35

The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem (1997) 1.35

The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol Cell Biol (1995) 1.32

L27, a novel heterodimerization domain in receptor targeting proteins Lin-2 and Lin-7. Trends Biochem Sci (2000) 1.30

Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol Biol Cell (1997) 1.30

C. elegans cell migration gene mig-10 shares similarities with a family of SH2 domain proteins and acts cell nonautonomously in excretory canal development. Dev Biol (1997) 1.26

Identification of autophosphorylation sites of HER2/neu. Cell Growth Differ (1990) 1.24

The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J Biol Chem (1995) 1.23

Molecular analysis of the X11-mLin-2/CASK complex in brain. J Neurosci (1999) 1.22

Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J Biol Chem (1995) 1.19

Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J Biol Chem (1999) 1.18

The prevalence and causes of visual impairment in indigenous Australians within central Australia: the Central Australian Ocular Health Study. Br J Ophthalmol (2010) 1.08

Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domains. J Biol Chem (2000) 1.03

Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. J Biol Chem (1996) 1.02

Influence of environmental temperature on the sleep-wakefulness cycle in the rat. Physiol Behav (1972) 1.02

Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors. J Biol Chem (1996) 1.00

Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene (1994) 0.99

The membrane-associated guanylate kinase protein MAGI-1 binds megalin and is present in glomerular podocytes. J Am Soc Nephrol (2001) 0.98

Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction. J Biol Chem (1996) 0.97

Functional analysis of the Numb phosphotyrosine-binding domain using site-directed mutagenesis. J Biol Chem (1998) 0.96

mLin-7 is localized to the basolateral surface of renal epithelia via its NH(2) terminus. Am J Physiol Renal Physiol (2000) 0.95

Interaction with mLin-7 alters the targeting of endocytosed transmembrane proteins in mammalian epithelial cells. Mol Biol Cell (2001) 0.93

Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J Biol Chem (1998) 0.92

13C NMR study of hepatic pyruvate carboxylase activity in tumor rats. Biochem Biophys Res Commun (1991) 0.92

Grb10: A new substrate of the insulin-like growth factor I receptor. Cancer Res (1996) 0.91

Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling. Bioessays (1993) 0.91

Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene (1995) 0.89

Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif. J Biol Chem (1996) 0.87

The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation. J Biol Chem (1997) 0.87

Endorphins are related to pain perception in coronary artery disease. Am J Cardiol (1987) 0.87

Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr Biol (1995) 0.85

Novel approaches to preventing ischemia-reperfusion injury during liver transplantation. Transplant Proc (2013) 0.84

Role of SH2-containing proteins in cellular signaling by receptor tyrosine kinases. Cold Spring Harb Symp Quant Biol (1992) 0.84

Effect of cocoa and green tea on biomarkers of glucose regulation, oxidative stress, inflammation and hemostasis in obese adults at risk for insulin resistance. Eur J Clin Nutr (2012) 0.84

Total synthesis of quinine and quinidine. I. J Am Chem Soc (1970) 0.83

Positive versus negative signaling of LET-23: regulation through the adaptor protein, SEM-5. Sci STKE (2000) 0.83

Dog tapeworm infestation in an infant. Am J Dis Child (1983) 0.82

Function of PTB domains. Curr Top Microbiol Immunol (1998) 0.82

Trends and geographic variations in hospital admissions for asthma in Victoria. Opportunities for targeted interventions. Aust Fam Physician (2003) 0.82

Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling. Oncogene (1999) 0.81

Student selection for physical therapy education: a project in progress. Phys Ther (1970) 0.81

Bilateral endogenous Candida endophthalmitis and chorioretinitis following toxic megacolon. Eye (Lond) (1996) 0.80

Cyclosporine induced alterations in vasopressin signalling in the glomerular mesangial cell. Clin Invest Med (1989) 0.80

Neonatal mononuclear cell metabolism: further evidence for diminished monocyte function in the neonate. Pediatr Res (1979) 0.79

Primary anastomotic bonding in polytetrafluoroethylene grafts? J Vasc Surg (1987) 0.79

Interaction of epidermal growth factor with vasoactive hormones in the regulation of phospholipase A2. J Basic Clin Physiol Pharmacol (1992) 0.79

Isolation and partial characterisation of a 26 kilodalton antigen from Plasmodium falciparum recognised by an inhibitory monoclonal antibody. Mol Biochem Parasitol (1988) 0.77

Haemodynamic changes and oxygen uptake during crossclamping of the thoracic aorta in dexmedetomidine pretreated dogs. Can J Anaesth (1992) 0.77

Potential wildlife sources of Yersinia pseudotuberculosis for farmed deer (Cervus elaphus). N Z Vet J (1984) 0.77

Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses. Cell Regul (1991) 0.77

Augmentation of surface contour by subcutaneous injections of silicone fluid. A current report. Plast Reconstr Surg (1973) 0.77

Episodic drug treatment in the management of paroxysmal arrhythmias. Am J Cardiol (1980) 0.77

A novel calcium signalling response in the breast cancer cell line MDA-468. Biochem Biophys Res Commun (1989) 0.76

Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinase. J Antibiot (Tokyo) (1999) 0.76

Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin. Biochem Biophys Res Commun (2001) 0.76

Cloning and mutational analysis of the Shc-phosphotyrosine interaction/phosphotyrosine-binding domain. Methods Mol Biol (1998) 0.76

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry (1998) 0.76

Blood-letting in bulimia nervosa. Br J Psychiatry (1993) 0.75

Nonstress testing in a physician's office--a five-year experience. West J Med (1985) 0.75

Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg (1991) 0.75

Angiotensin and adrenoceptors in the hemodynamic response to aortic cross-clamping. Arch Surg (1992) 0.75

H1 and H2 receptor antagonists and hepatic oxygen supply-demand relationship in pigs. Can J Anaesth (1991) 0.75

Effects of crossclamping the descending aorta on the high-energy phosphates of myocardium and skeletal muscle. A phosphorus 31-nuclear magnetic resonance study. J Thorac Cardiovasc Surg (1993) 0.75

Hemodynamics and oxygen uptake below and above aortic occlusion during crossclamping of the thoracic aorta and sodium nitroprusside infusion. J Thorac Cardiovasc Surg (1990) 0.75

Humoral factors and hemodynamics during cross-clamping of the thoracic aorta. J Cardiothorac Vasc Anesth (1991) 0.75

Effect of mecillinam on peptidoglycan synthesis during the division cycle of Salmonella typhimurium 2616. Res Microbiol (1994) 0.75